Phase IB study to evaluate the biological activity of indibulin using positron-emission tomography scans.
Phase of Trial: Phase I
Latest Information Update: 10 Oct 2013
At a glance
- Drugs Indibulin (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
- Sponsors ZIOPHARM Oncology
- 01 Jul 2009 Additional lead trial investigator identified as Jonathan Lewis as reported by ClinicalTrials.gov.
- 01 Jul 2009 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
- 01 Jul 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.